Target intelligence / Profile preview

Streptococcal M protein Emm55 (Emm55)

Target
Emm55
Molecular classification
Surface protein, Virulence factor
01

Overview

The Streptococcal M protein Emm55 is a surface-exposed, fibrillar coiled-coil dimer on Group A Streptococcus (GAS) that extends from the bacterial cell wall, serving as a major virulence factor. It inhibits phagocytosis by binding host proteins like fibrinogen, IgG, and plasminogen (including via an S-region motif shared with M1 and M64), promotes adherence to epithelial cells, and aids in overcoming innate immunity through interactions along its length. Emm55 belongs to an emm-type classification, where its N-terminal sequence defines strain typing (emm-typing by CDC) among over 275 identified types. The full protein structure is highly predictive from this N-terminal region, showing high conservation (88-100% identity) within its specific emm-type, though lengths can vary significantly across different emm patterns (e.g., A-C being longest, E shortest). Structural features include heptad repeats stabilizing the coiled coil, contributing to its functionality. In disease, Emm55 drives GAS pathogenesis in infections ranging from pharyngitis to invasive disease, with emm-types like Emm55 correlating to specific emm patterns (e.g., potentially D or E) linked to tissue tropism and epidemiology. While Emm55 is a key vaccine antigen target, its extensive sequence diversity across hundreds of emm-types poses significant challenges for developing broadly protective vaccines. No approved therapeutics directly target Emm55; rather, vaccine development focuses on leveraging M protein conservation.

Other names
M55 proteinEmm55 M protein
02

Biological functions

Inhibits phagocytosisPromotes adherence to host epithelial cellsBinds host proteins (e.g., fibrinogen, IgG, plasminogen)Immune evasion
03

Disease associations

Infection (Group A Streptococcus infections, including invasive disease)
04

Safety considerations

Antigenic diversity may complicate vaccine efficacyPotential for autoimmunity from cross-reactivity with host tissues

Beyond the preview

Go deeper on Streptococcal M protein Emm55 (Emm55).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Streptococcal M protein Emm55 (Emm55).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call